News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Turney Patricia A.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/08/2023 |
4
| Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 831 shares
@ $15.2635, valued at
$12.7k
|
|
03/06/2023 |
4
| Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Granted 18,000 shares
@ $0 Granted 47,600 options to buy
@ $15.82, valued at
$753k
|
|
03/02/2023 |
4
| Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 936 shares
@ $16.1663, valued at
$15.1k
Sold 1,414 shares
@ $15.8183, valued at
$22.4k
Sold 18 shares
@ $16.52, valued at
$297.4 |
|
08/04/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
03/30/2022 |
4/A
| Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Exercised 25,328 options to buy
@ $6.52, valued at
$165.1k
|
|
03/25/2022 |
4
| Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Granted 25,328 shares
@ $6.52, valued at
$165.1k
Disposed/sold 25,328 options to buy
@ $6.52, valued at
$165.1k
|
|
03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
03/03/2020 |
4
| Turney Patricia A. (Senior VP, Manufacturing) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Granted 9,000 shares
@ $0 Granted 27,000 options to buy
@ $27.61, valued at
$745.5k
|
|
01/30/2020 |
3
| Turney Patricia A. (Senior VP, Manufacturing) has filed a Form 3 on Arcutis Biotherapeutics, Inc. |
|
|